Literature DB >> 20162048

Whether co-administration of garlic has negative influence on Scutellaria baicalensis Georgi in treating models rats with pelvic inflammation?

Jue Zhou1, Fan Qu, Yongping Yu, Rui Nan.   

Abstract

The research was to explore whether co-administration of garlic has negative influence on Scutellaria baicalensis Georgi (Scutellaria baicalensis) in treating models rats with pelvic inflammation. Twelve model rats were randomized into a Scutellaria baicalensis group and a Scutellaria baicalensis+garlic group with six in each group for pharmacokinetic analysis. Twenty-four rats were randomized into a Scutellaria baicalensis group, a Scutellaria baicalensis+garlic group, a model control group and a normal control group with six rats in each group for detecting the serum levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6) with enzyme-linked immunosorbent assay (ELISA). The results showed that in the Scutellaria baicalensis group, the maximum concentration (C(max)) of baicalin, area under the plasma concentration-time curve (AUC) and the time to C(max) (T(max)) were significantly higher and apparent clearance (CL/F) were significantly lower than those of Scutellaria baicalensis+garlic group. The serum levels of TNF-alpha and IL-6 in the Scutellaria baicalensis group were both significantly lower than Scutellaria baicalensis+garlic group. It was then concluded that garlic not only had negative influence on the absorption of active compounds in Scutellaria baicalensis, but decreased the curative effects of Scutellaria baicalensis in treating model rats with pelvic inflammation. Garlic should not be co-administered with Scutellaria baicalensis.

Entities:  

Keywords:  Scutellaria baicalensis Georgi(Scutellaria baicalensi); garlic (Allium sativum); pharmacokinetics analysis

Year:  2008        PMID: 20162048      PMCID: PMC2816526          DOI: 10.4314/ajtcam.v6i1.57080

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  8 in total

1.  The effect of garlic supplements on the pharmacokinetics of saquinavir.

Authors:  Stephen C Piscitelli; Aaron H Burstein; Nada Welden; Keith D Gallicano; Judith Falloon
Journal:  Clin Infect Dis       Date:  2001-12-05       Impact factor: 9.079

2.  In vivo tumor necrosis factor production in women with salpingitis.

Authors:  M Toth; J Jeremias; W J Ledger; S S Witkin
Journal:  Surg Gynecol Obstet       Date:  1992-05

3.  Studies on Scutellariae radix. VII. Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae radix.

Authors:  M Kubo; H Matsuda; M Tanaka; Y Kimura; H Okuda; M Higashino; T Tani; K Namba; S Arichi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-07       Impact factor: 1.645

4.  The association of interleukin 6 with clinical and laboratory parameters of acute pelvic inflammatory disease.

Authors:  H E Richter; R L Holley; W W Andrews; J Owen; K B Miller
Journal:  Am J Obstet Gynecol       Date:  1999-10       Impact factor: 8.661

5.  Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide.

Authors:  Y C Chen; S C Shen; L G Chen; T J Lee; L L Yang
Journal:  Biochem Pharmacol       Date:  2001-06-01       Impact factor: 5.858

Review 6.  Herb-drug interactions: a literature review.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi Lui Ho; Sui Yung Chan; Paul Wan Sia Heng; Eli Chan; Wei Duan; Hwee Ling Koh; Shufeng Zhou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  The modulatory role played by TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in the mouse model of pleurisy.

Authors:  T S Fröde; G E Souza; J B Calixto
Journal:  Cytokine       Date:  2001-02-07       Impact factor: 3.861

8.  Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects.

Authors:  M I Mohammed Abdul; X Jiang; K M Williams; R O Day; B D Roufogalis; W S Liauw; H Xu; A J McLachlan
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.